Display Single Record

FOI Request

Disclosure ID

FOI/05341

Request Date

December 5, 2022

Subject

Pharmacy

Description

Q1. How many patients have been treated (for any condition) in the last 4 months with:
– Benralizumab
– Omalizumab
– Reslizumab
– Mepolizumab

Q2. Of the patients treated in the last 4 months with any of the above products, please provide the number of patients by the following age-groups:
–  Age 6-11
– Age 12-17
– Age 18 and above

Q3. How many patients have been treated in the last 4 months with Dupilumab for:
–  Asthma ONLY
– Chronic rhinosinusitis with nasal polyps ONLY

Q4. How many patients have been treated in the last 4 months with Omalizumab for:
– Asthma ONLY
– Chronic rhinosinusitis with nasal polyps ONLY
–  Chronic Spontaneous Urticaria ONLY

Response

Please see accompanying document 

Attachment 1

response_05341.pdf

Attachment 2

Attachment 3

Attachment 4

Attachment 5

Attachment 6

Attachment 7

Attachment 8

Attachment 9